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????????????
It is known that the midbrain periaqueductal gray 
（PAG） plays a crucial role in the descending pain 
modulating system. Many reports have demonstrated 
that electrical or chemical stimulation of the ventrolat-
eral subdivision of the PAG （vlPAG） suppresses a 
number of nociceptive reflexes and results in profound 
analgesia1〜5）.
GABAergic neurons have been identified in the 
PAG6,7） and they play an important role in the de-
scending pain control. Application of GABAA receptor 
antagonists, such as bicuculline or picrotoxin, evokes 
antinociception and can potentiate morphine-induced 
analgesia8 , 9）. Serotonergic neurons have also been 
shown to be involved in the PAG. Clements et al.10） re-
vealed the presence of serotonin-like immunoreactive 
cell bodies located in the ventrolateral and ventrome-
dial regions of the caudal PAG. Consistent evidence 
has shown that the antinociception elicited by the elec-
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???????
The midbrain periaqueductal gray （PAG） plays a crucial role in the descending pain modulating system. 
NMDA receptors （NMDARs） and serotonergic and GABAergic neurons have been identified in the PAG 
and are involved in the descending pain-modulating pathway. We characterized the NMDA component of 
the excitatory synaptic transmission within the ventrolateral subdivision of the PAG （vlPAG） using a whole 
cell patch clamp technique and then detected the expression of tryptophan hydroxylase （TPH）, serotonin 
synthesizing enzyme, and glutamate decarboxylase （GAD）, GABA synthesizing enzyme to understand the 
vlPAG intrinsic neurotransmission. The NMDA/non-NMDA ratio and the decay time constant of the 
NMDA component of the non-serotonergic GABAergic neurons were significantly larger than those of non-
serotonergic non-GABAergic neurons and serotonergic GABAergic neurons. This suggests that the non-se-
rotonergic GABAergic neurons might play an important role in the descending pain modulating system 
originated from the PAG. The decay time constant of the NMDA component of the non-serotonergic non-
GABAergic neuron was significantly greater in the mouse with partial sciatic nerve ligation compared with 
the control mouse. These results suggest that the subunit composition of the NMDAR in the non-serotoner-
gic non-GABAergic neurons change during neuropathic pain.
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trical stimulation of vlPAG is regulated by the seroton-
ergic mechanism11,12）.
It has been suggested that NMDARs are involved in 
the nociceptive pathway including the PAG13〜15）. The 
intra-vlPAG infusions of NMDAR agonists provoke 
high-magnitude antinociception16〜18）. Electrophysiolog-
ical investigation in the vlPAG neuron has revealed 
that excitatory synaptic transmission was mediated by 
glutamate acting on NMDA and non-NMDA recep-
tors19）.
The aim of this report is to characterize the gluta-
matergic synaptic transmission in vlPAG neurons in 
reference to the expression of serotonin and GABA, 
and to find changes of those characteristics by neuro-
pathic pain. Using control mice and mice with the par-
tial ligation of sciatic nerve, we characterized the 
NMDA component of the excitatory synaptic transmis-
sion within the vlPAG, using a whole cell patch clamp 
technique and then classified the recorded neurons 
based on their expression of mRNA for tryptophan hy-
droxylase （TPH）, serotonin-synthesizing enzyme, and 
glutamate decarboxylase （GAD）, GABA-synthesizing 
enzyme, using single-cell reverse transcription-poly-
merase chain reaction （RT-PCR）, to help gain insight 
into the vlPAG intrinsic neurotransmission.
???????
1. Animals
Adult male ICR mice （5-6 weeks old） were used in 
this experiment. The animals were kept at controlled 
room temperature under a 12-h/12-h light/dark cy-
cle. The care and use of the animals were in accor-
dance with the Dokkyo University Animal Care and 
Use Committee and the guidelines of the International 
Association for the Study of Pain20）.
2. Surgery
Mice were anesthetized by an intraperitoneal injec-
tion of sodium pentobarbital （50 mg/kg）. The left sci-
atic nerve was partially ligated according to the proto-
col for rats as described by Seltzer et al.21）. In sham-
operated control mice, the sciatic nerve was exposed 
but not ligated.
3. Assessment of behavioral mechanics
Mice were placed on an elevated plastic mesh floor 
covered with a clear plastic box （height, 15 cm；diam-
eter, 12 cm） and the withdrawal threshold to mechani-
cal stimulation was determined. The mechanical stimu-
lus was applied from below the plantar aspect of the 
hind limb, ipsilateral to the partial nerve ligation by 
means of an Electro von Frey （Model 1601；IITC Inc., 
Woodland Hills, CA）. The lowest force from five tests 
that induced a withdrawal response was considered 
the withdrawal threshold. The measurements were 
made from 2 days before the surgical operation 
through 10 days after the surgical operation.
4. Preparation of midbrain slices including PAG
Brain slices were made according to the methods 
described by Ye et al.22）. Briefly, the mice were anes-
thetized with pentobarbital and decapitated. The 
brains were quickly removed and blocked. Transverse 
slices （350 mm） were cut by a vibratome through the 
entire rostro-caudal extent of the PAG. Slices were 
transferred to a recording chamber, which was contin-
ually superfused （2-3 ml/min） with an artificial cere-
bral spinal fluid of the following composition （in mM） 
：124 NaCl, 3.2 KCl, 1.25 NaH2PO4, 26.0 NaHCO3, 2.5 
CaCl2 , and 1 .3 MgCl2 equilibrated with 95％ O2−5％ 
CO2. When necessary, MgCl2 was not included to make 
a nominally Mg2＋-free solution.
5. Whole cell patch clamp recordings
Whole cell recordings were made from visually iden-
tified vlPAG cells of the brain slices. Patch pipettes 
were filled with an internal solution having the follow-
ing ionic composition （mM）：potassium gluconate, 
123；KCl, 14；sodium gluconate, 2；（ethylenebis （ox-
ononitrilo）） tetraacetate, 1；HEPES, 10；pH neutral-
ized to 7.4 with KOH. When making perforated patch 
clamp recordings, amphotericin B （6 mg/ml） was in-
cluded in the pipette solution. The progress of perfora-
tion was monitored by measuring the access resistance 
deduced from the amplitude of the capacitive tran-
sients in response to repetitive 10mV hyperpolarizing 
steps. The DC resistance of the pipettes filled with the 
internal solution was 5-10 MW. All experiments were 
performed at room temperature.
Excitatory postsynaptic current （EPSC） was evoked 
at 0.1 Hz using a stimulating electrode filled with 1 M 
NaCl with its tip （diameter, ca. 3 mm） placed about 
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200 mm away from the recording site. All recordings 
were made in the presence of strychnine （2.0 mM）, bi-
cuculline （10 mM）. Non-NMDA component of the 
EPSC was recorded in the presence of APV （50 mM） 
at holding potential −70 mV. NMDA component of the 
EPSC was recorded in the presence of CNQX （30 
mM） in the nominally Mg2＋-free solution at a holding 
potential of −70 mV. EPSCs were recorded in the volt-
age clamp mode using an Axopatch 200B patch clamp 
amplifier （Axon Instruments, USA）. Data were sam-
pled at a rate of 10.0 kHz through a Digidata 1230 in-
terface （Axon Instruments）. pCLAMP （Axon Instru-
ments） was used to analyze the data.
6. Single-cell RT-PCR
After whole cell recordings were made, the neurons 
were aspirated into another pipette according to a pre-
viously described protocol 23）. The collecting pipette 
had a tip diameter of about 3-5 mm and contained 2 m l 
of Ca2＋- and Mg2＋-free phosphate-buffered saline so-
lution. The neurons were then ejected into thin-walled 
autoclaved PCR tubes by applying a gentle positive 
pressure, and immediately frozen and stored at −80℃ 
until use. The PCR tubes contained 2 m l MgCl2 （25 
mM）, 2 m l 10 PCR buffer （200 mM Tris-HCl, 500 mM 
KCl）, 0 .5 m l RNase inhibitor （40 ,000 units/ml）, 2 m l 
nonionic detergent IGEPAL CA-630 （5％）, and 5 m l 
DEPC treated water.
On the following day, analysis was performed using 
IGEPAL CA-630 at room temperature for 5 min fol-
lowed by the addition of the reverse transcription mix-
ture. The RT mix contained 1 m l oligo （dT） primers 
（0.5 mg/m l）, 2 m l mixed deoxynucleotide triphosphates 
（dNTPs, 10 mM）, 2 m l dithiothreitol （0 .1 M）, 0 . 5 m l 
Rnase inhibitor （40,000 units/ml）, and 1 m l SuperScript 
II RT （200 Units/m l）. The reaction mixture was incu-
bated at 42℃ for 50 min. Subsequently, the sample 
was heat-inactivated at 70℃ for 15 min.
The PCRs were performed using the protocol of Fu-
kushima et al.24） in a 50-m l volume containing 20 mM 
Tris-HCl, 50 mM KCl, 2.5 mM MgCl2, 0.2 mM dNTPs, 
and 2 .5 units Taq DNA polymerase. The entire RT 
product was used for the first PCR, and 1-2 m l of the 
first PCR product was used for the second PCR. The 
primers were designed to target three genes, NSE, 
TPH, and GAD67. NSE was used as a positive control 
and we discarded the cells in which NSE RT-PCR 
product was absent. Primers used for detection of NSE 
were 5-ATAGTGGGCGATGACCTGAC-3 and 5-AT 
GAACGTGTCCTCCGTTTC-3 （200-bp product；
GenBank accession # NM 013509）. Primers used for 
TPH detection were 5-TCCTTTGACCCAAAGACG 
AC-3 and 5-AGGTCCTGCACCACATTCTC-3 （215-
bp product；GenBank accession # NM 173391）. Prim-
ers used for GAD67 detection were 5 -CAAGTTCTG-
GCTGATGTGGA-3 and 5-GCCACCCTGTGTAGC 
TTTTC-3 （231-bp product；GenBank accession # 
NM 008077）. These primers were used for both the 
first and second PCR amplification. Each primer was 
individually used in the second PCR. The concentra-
tion of primers was 20 nM each in the first PCR and 
200 nM in the second PCR. The thermal cycler （Gene 
Amp 2400, Perkin Elmer） was programmed for 35-40 
cycles of 1 min at 94℃ denaturation, 1 min at 54-59℃
for annealing, and 1 min at 72℃ for elongation. The 
second PCR products were visualized by staining with 
ethidium bromide and separated by agarose gel elec-
trophoresis. All the products were sequenced using 
dye terminator chemistry （Applied Biosystems） and a 
DNA sequencer （Model 377 , ABI） and matched the 
published sequences. All the reagents for the RT-PCR 
were obtained from GIBCO BRL, except the RNase in-
hibitor （TOYOBO）, IGEPAL CA-630 （Sigma） and 
Taq DNA polymerase （Takara）.
7. Statistical analysis
Results are expressed as mean±SEM. Statistical 
analysis of the results was performed by un-paired t 
test for the analysis of effects of partial ligation of sci-
atic nerve on the characteristics of NMDA component 
and by 1way ANOVA with Dunnett’s Multiple Com-
parison Test for the analysis of characteristics of the 
NMDA component of four phenotypes. Differences 
were considered significant at the level of p＜0.05.
???????
1. Four phenotypes of neurons were distinguished by 
single cell RT-PCR
We collected individual neurons in the vlPAG after 
the recordings of synaptic current. The RNA from the 
neurons was extracted and processed for use in sin-
gle-cell RT-PCR for NSE, TPH, and GAD67 to identify 
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the gene expression of the neuron-specific enolase, se-
rotonin-synthesizing enzyme, and GABA-synthesizing 
enzyme. Examples of RT-PCR data are shown in Fig-
ure 1A. Presence of TPH RT-PCR product served as 
an indicator of the presence of serotonin in the neuron. 
The presence of DAD67 RT-PCR product served an 
indication that the neuron contained GABA. Of the 79 
NSE-positive cells, 48 expressed THP （61％） （seroton-
ergic） and 51 expressed GAD67 （65％） （GABAergic）. 
Co-expression of these markers was found in 35 neu-
rons （44％）. Therefore, four phenotypes of neurons 
were distinguished （Fig. 1A）, neurons containing sero-
tonin and GABA （named as serotonergic GABAergic 
neuron） （n＝35, 44％）, neurons containing serotonin 
but not GABA （named as serotonergic non-GABAer-
gic neuron） （n＝13, 17％）, neurons containing GABA 
but not serotonin （ named as non-serotonergic 
GABAergic） （n＝16 , 20％）, and neurons containing 
neither serotonin nor GABA （named as non-seroton-
ergic non-GABAergic） （n＝15, 19％）. Our next step 
was to test whether the four different phenotypes 
were different in their synaptic functions.
2. NMDA and non-NMDA components of the vlPAG 
neurons
Excitatory postsynaptic current （EPSC） was record-
ed using a stimulating electrode placed about 200 mm 
away from the recording site. The NMDA and non-
NMDA components of the EPSC were pharmacologi-
cally distinguished. Relative magnitude and decay ki-
netics of NMDA component of the EPSCs were 
examined. Typical examples of NMDA and non-NM-
DA components are shown in Figure 1B. The ratio of 
the peak value of NMDA component to that of non-
NMDA component （NMDA/non-NMDA ratio） of the 
non-serotonergic GABAergic neuron was larger than 
that of the serotonergic GABAergic neuron （Fig. 1B）.
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????????　 Examples of the RT-PCR and typical examples of recorded EPSC in the vlPAG. （?） Agarose gel 
analysis of the RT-PCR product of a single vlPAG neuron, expressing NSE （labeled with N）, TPH 
（labeled with T）, and GAD67 （labeled with G） transcripts. Based on the expression of TPH or 
GAD67, we identified four phenotypes, serotonergic GABAergic, serotonergic Non-GABAergic, 
non-serotonergic GABAergic, and non-serotonergic non-GABAergic neurons. （?） NMDA and 
non-NMDA component of EPSC were recorded using whole cell patch clamp technique. NMDA 
component of a typical example of synaptic current recorded in a non-serotonergic GABAergic 
neuron （upper trace） was larger than that recorded in a serotonergic GABAergic neuron （lower 
trace）. Electrical stimulation was applied at the time indicated by an arrow.
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3. NMDA/non-NMDA ratio of the non-serotonergic 
GABAergic neurons is significantly larger
Mean values of NMDA/non-NMDA ratios in the 
four different phenotypes of neurons were as follows；
0 . 4 7 6±0 . 0 4 5 4 （ n＝1 4） in the non-serotonergic 
GABAergic neurons, 0 . 335±0 .0338 （n＝12） in the 
non-serotonergic non-GABAergic neurons, 0 . 344±
0.0305 （n＝29） in the serotonergic GABAergic neu-
rons, and 0 .398±0.0883 （n＝6） in the serotonergic 
non-GABAergic neurons. The NMDA/non-NMDA ra-
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????????　 Characteristics of the NMDA component of four phenotypes in the vlPAG. （?） The decay of 
NMDA EPSC was fit with a biexponential function having a fast （t fast） and a slow （t slow） decay 
time constant. Superimposed biexponential function fits well with the decay phase of the NMDA 
component. Two typical examples with different phenotypes were shown. （?） Ratio of NMDA 
component to non-NMDA component of EPSC in the four different phenotypes. The NMDA/non-
NMDA ratio of the non-serotonergic GABAergic neurons was larger than those of other neuron 
types. The differences are significant when being compared with the non-serotonergic non-
GABAergic neurons and the serotonergic GABAergic neurons. （?） Decay time constant of NMDA 
component. The value of t slow of the NMDA component in the non-serotonergic GABAergic 
neurons was larger than those of the other neuron types. The differences are significant when 
being compared with that of non-serotonergic non-GABAergic neurons and the serotonergic 
GABAergic neurons. Vertical lines within each graph indicate mean values. ＊P＜0.05, ＊＊＊P＜0.005.
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tio in the non-serotonergic GABAergic neurons was 
larger than those of other phenotypes （Fig. 2B）. The 
differences are significant when being compared with 
those of non-serotonergic non-GABAergic neurons 
and serotonergic GABAergic neurons.
4. Decay time constant of the NMDA component in the 
non-serotonergic GABAergic neurons was significantly 
larger
We next examined the decay kinetics of NMDA 
component in the different neuron types. The decay 
phase of the NMDA component was fit with a biexpo-
nential function having a fast （t fast） and a slow （t slow） 
decay time （Fig. 2A, superimposed curves）. The cor-
responding mean values of t fast and t slow of the four dif-
ferent types of neurons were as follows；27.47±11.42, 
248.7±40.88 （n＝9） in the non-serotonergic GABAer-
gic neurons, 26.29±10.94, 117.0±16.59 （n＝10） in the 
non-serotonergic non-GABAergic neurons, 14 . 32±
3 . 9 2 8 , 1 0 0 . 7±14 . 4 8 （n＝22） in the serotonergic 
GABAergic neurons, and 25.43±15.03, 129.0±31.49 
（n＝4） in the serotonergic non-GABAergic neurons. 
The values of t fast of the four phenotypes were not sig-
nificantly different from each other. However, the val-
ue of t slow of the NMDA component in the non-sero-
tonergic GABAergic neurons was larger than other 
phenotypes （Fig. 2C）. The differences are significant 
when being compared with those of non-serotonergic 
non-GABAergic neurons and serotonergic GABAergic 
neurons.
5. Neuronal phenotypes of the mouse with sciatic nerve 
partial ligation
In the next step, we used mice that had received 
partial ligation of the sciatic nerve. We collected indi-
vidual neurons in the vlPAG of the mice with partial 
sciatic nerve ligation after the recordings of synaptic 
current. The extracted RNA was processed for exam-
ining the expression of NSE, TPH, and GAD67 using 
single-cell RT-PCR. Of the 61 NSE-positive cells, 24 
neurons expressed THP （39％）（serotonergic）, where-
as 47 neurons expressed GAD67 （77％）（GABAergic）. 
Co-expression of these markers was found in 22 neu-
rons （36％）. Therefore, four phenotypes of neurons 
were identified：serotonergic GABAergic （n＝22, 36
％）, serotonergic non-GABAergic （n＝2, 3％）, non-se-
rotonergic GABAergic （n＝25, 41％）, and non-seroton-
ergic non-GABAergic （n＝12, 20％）. In comparison to 
the control mouse, the percentage of the serotonergic 
non-GABAergic neurons decreased significantly, and 
that of the non-serotonergic GABAergic neurons in-
creased significantly in the mouse with partial sciatic 
nerve ligation. In the next step, the effects of ligation 
on the relative magnitude and decay kinetics of 
NMDA component of the EPSCs were examined.
6. The NMDA/non-NMDA ratio of non-serotonergic 
non-GABAergic neurons was significantly greater in 
the mouse with partial ligation
Mean values of NMDA/non-NMDA ratios in the 
four different phenotypes were as follows：0.440±
0.0392 （n＝22） in the non-serotonergic GABAergic 
neurons, 0.459±0.0354 （n＝12） in the non-serotoner-
gic non-GABAergic neurons, 0.401±0.0548 （n＝16） in 
the serotonergic GABAergic neurons, and 0 . 569±
0.00294 （n＝2） in the serotonergic non-GABAergic 
neurons. The NMDA/non-NMDA ratio of non-sero-
tonergic non-GABAergic neuron was significantly 
greater in the mouse with partial ligation than in the 
control mouse （Fig. 3A）. The ratios of the other neu-
ron types were not significantly different between the 
control mouse and the mouse with nerve ligation.
7 . Decay time constant of NMDA component of the 
non-serotonergic non-GABAergic neuron was signifi-
cantly greater in the mouse with partial ligation
We examined the effect of nerve ligation on the de-
cay kinetics of NMDA component. The mean values of 
t slow of the four different phenotypes were as follows：
1 3 9 . 8±3 9 . 5 1 （ n＝1 2） in the non-serotonergic 
GABAergic neurons, 571.7±180.8 （n＝8） in the non-
serotonergic non-GABAergic neurons, 179.4±98.61 （n
＝10） in the serotonergic GABAergic neurons, and 
68.92±0.0 （n＝1） in the serotonergic non-GABAergic 
neurons. The value of t slow of the NMDA component in 
the non-serotonergic GABAergic neurons was signifi-
cantly larger than those of the non-serotonergic non-
GABAergic neurons and the serotonergic GABAergic 
neurons. The value of t slow of the non-serotonergic 
GABAergic neuron was significantly smaller in the 
control mouse than in the ligation mouse. On the other 
hand, the value of t slow of the non-serotonergic non-
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GABAergic neuron was significantly greater in the 
mouse with partial ligation than in control mouse （Fig. 
3B）. The values of t slow of the other neuron types and 
the values of t fast of four phenotypes were not signifi-
cantly different between the control mouse and the 
mouse with nerve ligation.
??????????
1. Slow decay time constant of NMDA component in 
the non-serotonergic GABAergic neurons
The decay time constant of the NMDA component 
and the NMDA/non-NMDA ratio of the non-seroton-
ergic GABAergic neurons was larger than those of 
other neuronal phenotypes. Therefore, larger and lon-
ger depolarization would be elicited in the non-sero-
tonergic GABAergic neurons than in other neuron 
types in response to synaptic inputs. PAG receives no-
ciceptive ascending inputs originating from the spinal 
cord25 ,26） and projects to spinal cord via the rostral 
ventromedial medulla （RVM） to modulate nociceptive 
transmission in the spinal cord27,28）. Therefore, we pos-
tulate that the non-serotonergic GABAergic neurons 
might play an important role in the descending pain 
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????????　 Effects of partial ligation of sciatic nerve on the characteristics of NMDA 
component of four phenotypes in the vlPAG. （?） Effects of ligation on the 
NMDA/non-NMDA ratio in the four different phenotypes. The ratio of non-
serotonergic non-GABAergic neuron was significantly greater in the mouse 
with partial sciatic nerve ligation than in the control mouse. （?） Effects of 
ligation on the decay time constant of NMDA component. The value of t slow of 
the non-serotonergic non-GABAergic neuron was significantly greater in the 
mouse with partial sciatic nerve ligation than in the control mouse. Vertical 
lines within each graph indicate mean values. ＊P＜0.05, ＊＊＊P＜0.005.
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modulating system originating from PAG.
2. Slow decay time constant of NMDA component in 
the non-serotonergic GABAergic neurons might come 
from the NMDA subunit composition
The difference in kinetics of the NMDA component 
between the non-serotonergic GABAergic neurons 
and the other phenotypes might reflect the difference 
in the subunit composition of NMDAR. NMDARs are 
multimeric proteins that are composed of NR1 sub-
units along with subunits of the NR2 family （NR2A-
D）29,30）. Combination of molecular biology and electro-
physiological techniques have been used to show that 
expression of different glutamate receptor subunits un-
derlies the alteration of the functional properties of 
NMDARs, including the time course of EPSCs in neu-
rons31〜33）. The decay time constant of NR2A subunit 
was shorter than the other subunit NR2B-D. Based on 
the value of the recorded decay time constant of the 
non-serotonergic GABAergic neuron, 248 . 7±40 .88 
msec, we expect the non-serotonergic GABAergic 
neurons to be composed of more NR2B or C subunits 
and less NR2A subunits than other neuron type.
3. Characteristics of NMDA component of the non-sero-
tonergic non-GABAergic neuron changed after partial 
ligation of sciatic nerve
In the neurons of the spinal cord, the functional 
properties of the NMDAR change during neuropathic 
pain induced by peripheral nerve injury34,35）. Iwata et 
al. 36） showed that after partial ligation of the sciatic 
nerve, decay time constant of the NMDA component 
of the spinal cord neurons was increased and expres-
sion of NR2B subunit was increased. This suggests 
that the subunit composition of the sub-synaptic NM-
DARs in the superficial dorsal horn was altered by pe-
ripheral nerve injury. We found that the time constant 
of NMDA component of the non-serotonergic non-
GABAergic neuron in the vlPAG was significantly 
greater in the mouse with partial sciatic nerve ligation 
than in the control mouse. The decay time constant 
NMDAR could vary depending on subunit composi-
tion. The NR2A subunit is shorter, NR2B and C are 
longer, and NR2D is much longer. Therefore we specu-
late that a change of subunit composition underlies the 
increase in the decay time constant in the vlPAG neu-
rons after the partial ligation of the sciatic nerve.
4. Single cell RT-PCR analysis of GAD67 and TPH 
expressed in the vlPAG
We found a significant decrease in the percentage of 
the serotonergic non-GABAergic neurons and signifi-
cant increase in the percentage of the non-serotoner-
gic GABAergic neurons after partial sciatic nerve liga-
tion. A previous report showed that chronic pain 
induced by nerve injury elicited temporal changes in 
mRNA expression for substance P, dymorphin, and en-
kephalin in the spinal cord37）. Abraham et al. 38） also 
observed an increase in mRNA expression of opioids 
in spinal and supraspinal levels following spinal cord 
injury. Therefore, we propose that the change of in the 
mRNA expression for TPH and GAD67 in the vlPAG 
neurons occurred during neuropathic pain.
Serotonergic neurons in the PAG project to RVM39）. 
RVM directly projects to the spinal cord and modu-
lates the nociceptive transmission27,28）. Majority of the 
GABAergic neurons are interneurons6,40） and tonically 
inhibit the projection neurons in the PAG9,41）. There 
has been a hypothesis that disinhibition due to a de-
crease in tonic inhibition leads to the antinociceptive 
effect. Taking this hypothesis into consideration, the 
increase in the non-serotonergic GABAergic neurons 
and the decrease in the serotonergic non-GABAergic 
neurons lead to the decrease in antinociception that is 
elicited during neuropathic pain. One possible explana-
tion is that these phenotype changes might be related 
to a mechanism other than antinociception in the pain 
modulating system, for example, the hyperalgesia 42,43） 
elicited after nerve injury.
Another explanation for the phenotype change is 
that the serotonergic non-GABAergic neurons might 
be related to stress-induced sympathetic activity. The 
subpopulation of serotonergic projections from the vl-
PAG was shown to be capable of inhibiting stress-in-
duced sympathetic activity in the region of the C1 A 
neurons in the RVM44）. The C1 A neurons are impor-
tant sympathoexcitatory neurons that initiate pressor 
responses in the presence of stressful stimuli 45）. We 
speculate that the significant decrease in the percent-
age of the serotonergic non-GABAergic neurons could 
be related to the modulation of the sympathoexcitatory 
response elicited by chronic pain.
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5. Conclusion
We compared the NMDA/non-NMDA ratio and the 
decay time constant of the NMDA component of the 
synaptic current between four different neuronal phe-
notypes detected by single-cell RT-PCR based on the 
expression of TPH and GAD67. The NMDA/non-NM-
DA ratio and the decay time constant of the NMDA 
component of the non-serotonergic GABAergic neu-
rons were significantly larger than that of non-sero-
tonergic non-GABAergic neurons and the serotonergic 
GABAergic neurons. We also found that the decay 
time constant of NMDA component of the non-sero-
tonergic non-GABAergic neuron were significantly 
greater in the mouse with sciatic nerve partial ligation 
than in the control mouse. These results suggest that 
the non-serotonergic GABAergic neurons might play 
an important role in the descending pain modulating 
system originating from the PAG, and that the subunit 
composition of the NMDAR in the non-serotonergic 
non-GABAergic neurons change during neuropathic 
pain.
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